Emma M. Groarke, MD

Bone Marrow Failure Team and was appointed as an Assistant Research Physician in 2019. She obtained her medical degree from University College Dublin, Ireland in 2011 and subsequently completed both her general internal medicine and hematology training through the Royal College of Physicians, Ireland in 2019.

Dr. Groarke’s primary research focuses are immune aplastic anemia, telomere biology disorders, clonal hematopoiesis, MDS and VEXAS. She is an investigator running a number of clinical trials and other clinical studies at the NHLBI. Clinically, she sees patients in the outpatient clinic with bone marrow failure, MDS and VEXAS, and is an attending hematologist on both the benign hematology and blood and inherited disorders transplant and cellular therapy inpatient services. 

Publications

Efficacy of JAK1/2 inhibition in murine immune bone marrow failure

Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia

Venous and arterial thrombosis in patients with VEXAS syndrome

Eltrombopag added to immunosuppression for children with treatment-naïve severe aplastic anaemia

When to consider inherited marrow failure syndromes in adults